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This paper views the social landscape of biotechnology from the perspective of  emerging 
perceptions and attitudes of consumers to food biotechnology. The information from which 
consumers’ perceptions and attitudes may be discerned comes in several different forms.  
These include market responses to food biotechnology. Media attention paid to this issue is a 
second source of information.  The attention that is directed toward policy processes and 
regulatory institutions for food biotechnology, as this is translated through the political 
system into policy, is another expression of consumers’ attitudes. Information from publicly-
reported opinion polls and studies of social scientists of attitudes to biotechnology also 
provides insight on consumers’ perceptions. More emphasis is directed at the last two of 
these expressions of attitudes to food biotechnology in this paper, since at this point of time 
they are the most readily assessed of the various manifestations.   
Each of the four focal viewpoints of market reactions, media attention, policy 
processes, and polls and related studies indicates that levels of public and consumer 
awareness of food biotechnology are increasing.  The differences that are seen in the 
regulation of agricultural biotechnology in different regions of the world suggest that 
attitudes of different groups of people to biotechnology vary greatly and this is confirmed by 
opinion polls and related studies. The level of concern about agricultural biotechnology 
seems to be increasing as public awareness of this new technology increases. Background to 
this paper is provided through the following overview of divergences in attitudes to food 
biotechnology.  Subsequent discussions move to expressions of increased consumer interest 
in food biotechnology, differences in approaches to regulation of food biotechnology, the 
broad features of recent major opinion polls and some studies of consumers’ attitudes. The 





There has been increasing consumer awareness of biotechnology during the last 
decade, reflecting the considerable growth in the scope and use of biotechnological 
procedures and products that has occurred during this period. Research and applications of 
genetic modification (GM) have followed two main paths---agricultural applications, directed 
primarily at crops to this point, and medical applications, directed mainly at problems of 
human health
1.  A third area of biotechnology involves industrial and environmental 
                                                 
1 Biotechnology research with agricultural applications has focused on crops (such as corn, soybeans, canola), 
other plants used for human food (some fruits and vegetables), or for other human uses, such as tobacco (virus-
resistant tobacco has been a significant crop in China), animal feed, and fibre (cotton). GM microbial 
applications have been developed to produce the enzyme chymosin that is used in cheese production.  Other 
microbial GM treatments for food and feed processing uses have included vitamin production (OECD, 2000c). 
A cross-over area of agricultural and human biotechnology relates to the use of biotechnology in the 
development of animal health  and illness treatments, as with vaccines directed at problems of animal health and 
feed amendments or supplements. Animal biotechnology includes the biotechnological production and use in 
some, but not all, countries of otherwise naturally occurring growth hormones, such as rBST (Figure 1). Most 
agriculture and food GM applications to this point have been with plants and microbes; potential future uses of 
food/agricultural biotechnology are expected to be directed at fish (salmon) and, at a point even further in the 
future, may involve animals.   2 
 
applications that focus, for example, on biological treatment of water and sewage, using 
genetically modified bacteria.
2  
Much of the recent public debate about biotechnology has been directed at its use in 
food through agricultural applications. As pointed out in a recent report on agriculture by the 
Organisation for Economic Cooperation and Development, modern biotechnology has been 
associated with agriculture for more than 15 years but has only been a major “talking point” 
since  recent large scale introduction of genetically modified (GM) crops. GM crops were 
planted on an appreciable scale in 1996 and the level of their planting increased rapidly 
through the balance of the 1990’s (OECD, 2000a).  
The largest area of  GM crop plantings, by far, has been in the United States. Planting 
of GM crop varieties in Argentina, Canada, China and Australia have also been significant 
(OECD, 2000a,d; Europa, 2000a ). In addition to agricultural GM, focus on human medical 
applications of biotechnology has also greatly increased, as seen in the search for commercial 
diagnostic and therapeutic products, developed with the aid of molecular biology, that has 
flourished during much the same time period (Caulfield, 1998).  
The potential of benefits to consumers of agricultural biotechnology to this point has 
been viewed mainly to arise indirectly, through the modification of plant “input” traits that 
have increased crop yields and lowered inputs of agricultural chemicals, from currently 
licensed genetically-modified crop varieties which are herbicide or insect resistant  (See 
Figure 1 for the definitions of these and related terms used by the  Organisation for Economic 
Cooperation and Development)
3. For a future “second generation” of genetically modified 
crops, the potential for introduction or intensification of  plant “output” traits that are desired 
by customers is anticipated by crop scientists and others associated with agricultural 
biotechnology. Examples are “nutritionally dense” crops, vegetable oils with compositional 
qualities believed to have particular health benefits,  coloured cotton that would not need 
dying, and a variety of “functional foods.” GM plants with “value-enhanced” output traits 
that had already been licensed for use in the US by May 1999 included rapeseed with high-
lauric-acid oil, soybean with high-oleic acid oil, and a carnation variety with altered flower 
colour (USDA, 2001).  
Agricultural biotechnology is largely being developed in the private sector, for 
commercial crops. Pursuit of potential future benefits from improvements in crop yields and 
human nutritional components that are targeted to farmers and consumers in low income 
countries is not the priority of the North American and European “life-science” and “agro-
chemical” firms that have developed  and marketed GM seeds. Enhanced food security and 
nutritional quality are, however,  priorities for international public plant breeding through the 
international agricultural research centres that focus on agricultural research  directed to the 
                                                 
2 German firms are cited to lead in environmental biotechnology, accounting for 26 % of international patent 
applications (DFAIT, 2001). 
3 The complexity of biotechnology is reflected in the fact that although national regulatory agencies  apply 
definitions of “genetic modification” and “genetic engineering” that are embodied in Figure 1, this is not 
universally preferred. Some groups would prefer a broader definition of genetic modification that would include 
processes like accelerated mutagenisis that were introduced and applied in plant breeding prior to the 
development and use of modern molecular biological methods. A broader approach to identify genetically-
modified crops is, for example, the approach favoured by the Consumers’ Association of Canada (CAC, 2000). 
The term “modern biotechnology”  distinguishes GM  processes based on molecular biology from earlier-
developed processes of accelerated mutagenis.   3 
 
world’s poorest nations.
4 Two major issues for poor nations are potential benefits in food 
quality and food security from added nutritional qualities of basic crops such as rice, as 
through Vitamin A enhancement, and the prospect of drought or pest resistance for local 
crops, like yams, cassava and sweet potatoes (Serageldin, 1999; Falcon, 2000).   
From the perspective of more critical views of agricultural biotechnology, the benefits 
to this point seem to have accrued largely to the large multinational firms that are major 
developers, suppliers and promoters of agricultural inputs and to farmers in the adopting 
regions. The process of very rapid adoption by farmers in applicable regions suggests they 
have had strong profitability expectations, based mainly on yield increases and /or cost 
savings, but studies suggest that GM crop outcomes may have been mixed for many farmers. 
Farmers’ profits may have been variable and may have been more consistently evident for 
GM cotton than for some other crops; there have also been benefits of convenience to 
farmers in flexibility of field operations for herbicide-resistant crops (Europa, 2000a; OECD, 
2000d; USDA, 2001).   
Concerns have been expressed that agricultural biotechnology may be associated with 
health and environmental risks. The most evident expression of potential health risks for 
biotechnologically-derived foods is the possibility that allergens might be introduced into 
foods through biotechnological transfer of novel traits to GM plants. The other major focus 
of concern about agricultural biotechnology relates to possible environmental risks of 
genetically modified crops or other products, particularly the possibility of increased 
resistance to insects or other pests associated with insect-resistant crops, and to issues of 
possible gene escape or out-crossing that might, for example, add to problems of agricultural 
weediness, especially for  herbicide-resistant crops. Broader concerns have also been 
expressed by some people that GM is unnatural or irreligious. These arguments are 
summarised by Comstock (2000).  
  
Expressions of Increased Consumer Interest in Biotechnology 
 
Consumer sovereignty and market power 
 
   Consumers’ attitudes to food biotechnology are not only expressed indirectly, in the 
media, in polls, and in political reactions and decisions that lead to the formation of public 
policy and associated regulations. Consumers’ attitudes are also expressed directly through 
the market forces of consumer sovereignty—the decisions that consumers make on whether 
or not to buy certain food products. Anticipation of these decisions, coupled with the 
concerns of retailers and processors to avoid the costs and adverse publicity of food scares 
and food safety problems, has provided a powerful expression of market reaction to 
agricultural biotechnology in some regions and for some products. Observers of global food 
markets have noted an increasing concern with issues of food safety (Veeman, 1999). 
Pursuing, and being seen to be pursuing, a high level of emphasis on food safety has become 
a necessary marketing strategy for food processors and retailers. 
                                                 
4 The Consultative Group on International Agriculture Research [CGIAR] operates a network of agricultural 
and related research institutes in poor nations, funded largely by international donors. The 16 Centres of the 
CGIAR maintain gene-banks to protect biodiversity of plant materials. The  major purposes of the CGIAR 
centres are  to adapt or develop agricultural research suited to the conditions and problems of  farmers in poor 





                                  Figure 1:  Definitions of Agricultural Biotechnology 
 
•  Biotechnology is the application of cellular and molecular biology to diverse life processes 
and biological products. 
•  Modern agricultural biotechnology is the application of cellular and molecular biology to 
diverse agricultural production processes and products. One important aspect of this new 
agricultural biotechnology is in the breeding of new plant varieties as well as specialised 
micro-organisms through genetic modification (GM) or engineering. 
•  Genetically modified organism – GMO - refers to any plant, animal or micro-organism, or 
virus, which has been genetically engineered or modified. 
•  Insect resistant - Bt crops are engineered so as to contain a gene from the soil bacterium 
Bacillus thurigenesis that is specifically toxic to certain inspect pests. 
•  Herbicide resistant - HR-crops are genetically engineered to resist high doses of specific 
herbicides. 
•  Recombinant bovine somatotropin-rBST is a genetically engineered version of a naturally 
occurring hormone, which stimulates milk production in cows. 
 




  Pressure against the introduction and retail sale of GM food, and against its use in 
livestock feed, has been the subject of organised campaigns led by Friends of the Earth, 
Greenpeace, RAFI  and other non-government organisations (NGOs) since the mid-1990s. 
This campaign focused initially on supermarkets in the United Kingdom in 1996 and 1997.  
By 1998 several food retailers, including Iceland, Tesco, and Spar UK had followed the lead 
of Sainsbury’s in initiating policies to restrict or label GM foods and  publicised  this in their 
advertising and product labeling. By 1998 numbers of UK-based food manufacturing 
companies had also announced policies to restrict the use of GM ingredients in their food 
products. These moves were subsequently adopted by a number of  supermarkets in 
continental Europe, as with Carrefour (France) and  Delhaize (Belgium) amongst others. 
Some European food companies have now developed  affiliations directed to building  “non-
GM” supply chains  (Greenpeace, 2000; Europa, 2000a). The campaign against retail sale of 
GM food has continued to be pursued by Greenpeace and Friends of the Earth, as through the 
concerted efforts in the UK to highlight food products and food processors that have not 
adopted non-GM policies (Greenpeace, 2000; FOE, 2000). 
  The movement to restrict retail sale of GM food and the use of GM animal feeds has 
not made inroads in North America, although some multinational food processors, including 
some that are based in North America, have adopted policies of “no GM food ingredients.” 
Firms that now follow this policy include the foods division of Novartis (the parent company 
is headquartered in Switzerland) which is the manufacturer of  Gerber baby food. Other 
major US major food manufacturers, such as H. J. Heinz Company, have also adopted the 
policy not to use GM foods in baby food.  The Canadian-based company,  McCain Foods,   5 
 
has reversed its earlier policy favouring GM insect resistant potatoes to adopt a non-GM 
policy for its products. The Canadian-based distillery company, Seagram, is now following a 
policy of not using GM corn in its liquor. 
  Although the list of international food marketing companies that are following “no 
GM” strategies has increased over time, there does not currently seem to be a significant 
demand for “non-GM” foods in North America. The nature of labelling policies and 
marketing channels for genetically modified food in both Canada and the United States is 
evolving. The major form of food derived from agricultural biotechnology currently grown 
and distributed in Canada is canola oil, from licensed herbicide-resistant varieties of this 
oilseed crop. Protein in its meal byproduct, consumed mainly by livestock, is the focus of the 
genetic modification of canola, leading representatives of this industry to propose that the 
refined vegetable oil from the herbicide-resistant GM varieties of canola oil should not be 
classified as genetically modified.
5  
  In the United States, a wider range of GM crops is grown and processed than in 
Canada, including GM soybeans, corn and cotton. More GM products are in the pipeline 
(USDA, 2001). Some of these are nearing application for licensing in both Canada and the 
United States,  including herbicide-resistant wheat, which is currently opposed by the 
Canadian Wheat Board, and GM salmon, which has received very critical comment on 
environmental grounds by the Royal Society panel on food biotechnology (2001).  
  The negative market reactions to agricultural biotechnology that have been observed 
in Europe are impinging on the development and use of agricultural biotechnology in 
Canada. For example, a GM flaxseed variety was developed but not licensed in Canada, due 
to the concerns of adverse market consequences expressed by farmers’ organisations and 
exporters, since most Canadian flaxseed exports are to the European Union (EU). 
   Concern voiced in late 2000 and early 2001 by  farmers’ groups in Canada, Australia 
and the United States about the proposed licensing of GM wheat is not an expression of 
concern by farmers with the food safety of these varieties but reflects the fear of loss of 
export markets due to potential adverse reactions to GM crops of customers and regulators in 
major importing markets. For wheat exporters like Canada, the fears of adverse market 
reactions extend beyond the EU (the EU, where consumer concerns about GM foods were 
apparently first centred, is not a net importer, but an exporter of wheat).  Fears of adverse 
market reactions by customers for wheat are being extended to Japan, which is a premium 
wheat import market, where issues of food quality and safety are highly rated, and to a 
variety of other nations that are involved in world wheat trade (Manitoba Co-operator, 
2000a). The CWB anticipates that introduction of GM wheat would necessitate costly 
systems of product segregation to ensure identity preservation of non-GM wheat, and argues 
that licensing should not occur until benefits to farmers are clearer (CWB, 2001). 
  A reasonable hypothesis seems to be that demand for “non-GM” foods in Canada 
may show a market trend similar to organic foods. Organic foods account for a relatively 
minor but increasing proportion of Canadians’ food consumption.  The consumption of 
organic foods is also increasing in other countries. Despite the fact that interest in organic 
foods seems to be higher in Western Europe than in North America, organic foods only 
                                                 
5 This argument has been rejected by Canada’s national consumers group (CAC, 2000). However, the GM food 
labelling policy proposed in Australia and New Zealand will exempt from mandatory labelling, oils, starches 
and sugars where refining and processing remove any novel DNA or protein (Agra, 2000).  
   6 
 
account for a very small proportion of food consumption in Europe. For example, organic 
food is estimated to be 2.5% of food consumption in Germany (Economist, 2001) and 1% in 
the United States (USDA, 2000b).  Some two thirds of retail sales of organic food in the EU 
are through supermarkets (AAFC, 2000), which might suggest that this is becoming a more 
mainstream focus of food consumption. In North America also, organic foods are moving 
beyond the niche outlets of “health stores” to be sold in supermarkets. Although the organic 
segment of the market for food is very small in aggregate, this segment is forecast to increase 




One reflection of increasing public interest directed at agricultural biotechnology is 
the considerable increase in the levels of media coverage directed at this issue during recent 
years. For example, Einsiedel (2000) noted a steady increase in the number of press articles 
about biotechnology in the Canadian national newspaper, the Globe and Mail, in the years 
from 1995 (70 stories) to 1999 (170 stories). One aspect of worldwide media coverage is 
associated with the effective campaigns directed at mobilisation of public opinion that have 
been directed at agricultural biotechnology  by numbers of  international NGOs since the 
mid-1990’s. (Europa, 2000a). These have involved media campaigns, lawsuits and direct 
action. Much use has been made of the internet to set up discussion fora and databases and to 
organise petitions and lobbying actions. Various interests have been expressed by the groups 
involved in the  movement to lobby against GM food, initially known as “The Pure Food 
Campaign,” later known as the “Campaign for Food Safety” and now called “The Real Food 
Campaign”; these included the protection of consumers, sustainable development, and ethical 
concerns relating to genetic research (Europa, 2000a; Greenpeace, 2000; FOE, 2000).).  
The process of “global mobilisation” of public opinion, focused largely in Western 
Europe, has continued since 1996. Activist groups have filed lawsuits, as against the US 
Environmental Protection Agency in 1997 relative to the licensing and use of GM insect 
resistant crop varieties, and the 1998 suit challenging the US Food and Drug 
Administration’s review and labelling provisions for  food biotechnology. The  suit against 
the EPA was dismissed by the US Federal Court in 2000, as was the lawsuit challenging the 
FDA (BIO, 2000). Activist groups also proceeded in 1999 to engage in legal action against 
major biotechnology companies, alleging monopolistic practices;  numbers of other actions 
have involved petitions and demonstrations (Europa, 2000a). Instances of low-level  
“contamination” of imported seed with traces of GM varieties that had been licensed in North 
America, but not in the EU, also sparked demonstrations by environmental groups and have 
added to media attention (Agra, 2000).  
In the United States—and in Canada—counter-organisation groups have emerged 
with the mission of providing information to counteract information on agricultural 
biotechnology that is viewed to be incomplete or incorrect. These groups, which tend to 
represent scientists, industry and farmers, have also commissioned occasional reports (see for 
example the report of KPMG (2000) on potential costs of mandatory food labelling), as well 
as distributing information through web-sites and  newsletters. Other counter-activities have 
included lobbying for more research funding for biotechnology by scientists (both in Canada 
and the United States) and a US campaign, initiated  in October 1999 as the “Betterfood   7 
 
Campaign”, supported by the Grocery Manufacturers of America. the American Farm 
Bureau, and some 30 US food companies (Europa, 2000a)  
Despite the influence of the organised campaign against agricultural biotechnology in 
numbers of European countries, it would be a considerable overstatement to conclude that 
opposition to particular features of biotechnology comes only from extremist organisations.   
Intense opposition from a broadly-based range of NGO’s and civil groups, including the 
Consultative Group for International Agricultural Research and numbers of farmers’ groups 
and civil groups, drove Monsanto to its 1999 decision not to pursue the “terminator gene 
technology” that would render seed sterile
6. The decision not to approve the use of the milk-
stimulating hormone, rBST, for dairy cows in Canada, as in numbers of other countries, 
reflects the fact that issues of animal welfare can be an important social consideration, as can 
the fear of adverse reactions of consumers (Kuperis et al, 1999).  The activist campaign 
against GM foods seem to have influenced some European food retailers and processors not 
to use GM ingredients. Concern or opposition to GM food is expressed by numbers of people 
in Europe, including such opinion leaders in the United Kingdom as Britain’s Prince Charles 
and the  British Medical Association  (Europa, 2000a). 
The disrupted Seattle meeting of the World Trade Organisation in December 1999, 
and subsequent high profile international meetings of governments and related world 
organisations, have also been focal points for demonstrations against globalisation that have 
successfully sought media attention. These demonstrations have included expressions of 
opposition to agricultural biotechnology, expressed primarily, but not solely on 
environmental grounds. Hobbs and Plunkett (1999) note that GM food has become somewhat 
of a lightening rod for a coalition of different interest groups in Europe. In North America a 
coalition of disparate interest groups has emerged that reflects various concerns about 
globalisation, which includes focus on environmental fears attributed to GM food. 
 
Public Polls and Research Studies 
 
Increasing political and press awareness of biotechnology as a focus of public interest 
is also expressed in the monitoring of people’s perceptions of issues associated with 
biotechnology. This has occurred in recent years through a series of well-organised surveys 
of public opinions, mainly in Western Europe and  North America. As well, a number of  
assessments of attitudes and behaviour of people to some issues of biotechnology have been 
conducted by sociologists, economists, and communication specialists. These various sources 
of information are helpful in giving insight into consumers’ perceptions of biotechnology. 
Several of these studies are called on throughout this paper. A more extensive discussion of 
the information from some major polls is given in a later section.  
 
Public Policy Processes 
 
A major focus of public concern, and the recognition of this by  politicians and bureaucrats, 
relates to the heightened level of  interest expressed  in  public policies  and procedures  
                                                 
6 The approval of this joint patent, between Delta & Pine Land company and the USDA, for Technology 
Protection System or TPS, was intended to prevent seed-saving and subsequent unauthorised  use by farmers of 
patented gene technologies (USDA, 2001). As reflected by CGIAR rejection and the legislative ban, in 2000, on 
TPS in India, the plan for TPS technology antagonised many groups and created  fear among others.   8 
 
relating to biotechnology. One emphasis of public attention toward biotechnology is directed 
at encouragement of industrial growth associated with powerful new technologies. To this 
end the Government of Canada announced a “biotechnology strategy” as early as 1983; 
renewal of this strategy was subsequently highlighted in 1997 (CBAC, 2000). In turn, a 
variety of interest groups and NGOs have expressed interest and concerns relating to the 
regulatory processes involved in the testing of biotechnology-derived products, the 
assessment and approval procedures for these, their commercial development and use, and 
the existence and nature of any subsequent monitoring for unintended effects. Most of these 
discussions have been directed at agricultural biotechnology.   
A search for an internationally acceptable approach to the assessment of the safety of 
foods from plants with novel traits, that is, from plants with characteristics that have been 
introduced through biotechnology, started in the 1980’s. In the early 1990’s the Food and 
Agricultural Organisation (FAO), the World Health Organisation (WHO) and the OECD  
developed the concept of “substantial equivalence” for GM food when the “new food” is 
substantially equivalent to  analogous “traditional foods” (OECD, 2000bc). In the regulatory 
process for approval of foods from biotechnological processes in Canada, as in numbers of 
other countries, the finding of substantial equivalence has been an important element in the 
process of risk assessment. Less testing and a higher likelihood of licensing approval applies 
for GM foods that are considered substantially equivalent to traditional foods. However, 
numbers of countries are now emphasising “precautionary approaches” to issues of food 
safety, although the precise interpretation of this, as with the concept of substantial 
equivalence, may be open to interpretation. 
The differing interpretations and approaches that apply for GM foods are seen in the 
search for international consensus on principles to guide the labelling of GM food. This has 
been sought through the Codex Alimentarius Commission and its committee on food 
labelling, which operates within the food standards program of FAO and WHO. While there 
is consensus in this committee on the principles for labelling declarations when GM foods 
have compositional changes or allergen potential, consensus on other features of labelling 
GM/GE food had not been achieved through the Codex process by early 2001. Thus the “step 
3” discussion draft text of recommendations for the labelling of GM foods, distributed by the 
Codex committee in February 2001, continued to highlight  alternate forms of wording for 
foods or food ingredients that are the product of GM/GE techniques
7 (Codex, 2001). 
    The governmentally-requested panel established by the Royal Society of Canada 
(2001) on agricultural biotechnology advises dependence on a  “precautionary approach” to 
assess food biotechnology, an approach related to the “precautionary principle.” This reflects 
the desire of some consumer and environmental groups to place particular emphasis on 
avoiding possible injury where there may be a lack of evidence, and thus some uncertainty, 
of possible long-term effects of biotechnology. A precautionary approach is written into the 
statements of food safety policy of many countries (OECD, 2000e,f) and this concept is also 
embodied in some international agreements. The precautionary approach is included, for 
example, in the agreement of signatories to the World Trade Agreement on sanitary and 
phytosanitary standards for trade in livestock and crops, which provides for qualified 
provisional application of this approach, pending the development of more objective 
                                                 
7 This draft incorporates alternative wording  of  “no longer equivalent to/differ substantially from”  for 
“GM/GE”  foods  (Codex, 2001).  
   9 
 
measurements of risks. A precautionary approach to “genetically modified life forms” is also 
embedded in the Cartegena Protocol on Biosafety; like other international agreements, to be 
effective this requires ratification by the world’s major nations). However, there is little 
general agreement or generally accepted definition of the standards that would be involved in 
applying the precautionary principle in this context.  
Some groups have argued for a very broad application of the concept of precautionary 
principle (OECD, 2000b). Other groups, like the expert panel of the Royal Society of Canada 
(2001), see a precautionary approach as not necessarily inconsistent with the approach of 
substantial equivalence.  This panel advocated more transparency, research and arms length 
review of the application of the concept of substantial equivalence in Canada’s regulatory 
system for food to assure that regulatory screening and assessment is applied in a 
precautionary manner.  
The considerable room for debate in approach, definitional process and regulatory 
procedures for GM products has led to numbers of  international efforts to seek consensus on 
concepts, standards and criteria relating to genetically modified food and more common 
ground in the ways these are applied in practice. The recent OECD report on the safety of 
novel foods and feeds notes the possibility that food safety concerns may increase with the 
“next generation” of agricultural biotechnology, since changes in output traits are expected to 
give products that are less likely to be substantially equivalent to traditional foods. Thus 
continuing reviews are recommended (OECD 2000c).
8 The Codex intergovernmental task 
force on foods derived from biotechnology and the recent OECD task force on novel foods 
and feeds are only two of the bodies that have been the focus of recent international 
discussions on these issues (OECD, 2000ba,c). Discussions in  a variety of intergovernmental 
working parties and committees that seek consensus on the standards and criteria for GM 
foods can be expected to continue.  
One focus of public discussion about regulatory procedures concerns the role of the 
public in the process of regulatory review of biotechnology. There has been growing interest 
in issues of food safety in Canada, and in numbers of other nations, in recent years (Veeman, 
1999). Agencies like the Canadian Food Inspection Agency (CFIA) are tending to place more 
emphasis on public communication, through their web-site, consultation processes and 
reporting, than was the case in earlier years.  Recognition within the federal government of 
the need for more external assessment and public participation in the regulatory processes for 
food biotechnology is seen in several recent initiatives. These include the November 2000 
invitation from Health Canada, CFIA, and Environment Canada to the Royal Society of 
Canada to commission an expert panel to provide advice relative to new food products 
developed through biotechnology. A further federal initiative in 1999 to seek public input 
was through the establishment of a government-appointed Canadian Biotechnology Advisory 
Committee. The purpose stated for this committee is to advise legislators on broad  issues of 
public policy, such as the patenting of various life forms, through consultation with experts 
                                                 
 
8Continuing efforts in the search for international consensus on standards and procedures for GM food 
assessment is also one of several recommendations by the Chair of the recent OECD Conference on the 
Scientific and Health Aspects of Genetically Modified Foods, hosted by the Government of the United 
Kingdom, that was held in Edinburgh in 2000. That conference  was one component of a program of assessment 
of biotechnology and other aspects of food safety that is being undertaken by the OECD at the invitation of  
heads of state and members of government of the “Group of Eight” large nations.    10 
 
and members of the public. A process of public consultation on food biotechnology is being 
pursued through this agency in 2001 (CBAC, 2000). 
A related focus of public discussion about biotechnology regulation is the public 
availability of information about the assessment and decision-making for licensing 
agricultural biotechnology. There are issues of proprietary information where patenting of 
biotechnology is involved. As well, firms are generally reluctant to have information released 
that may be informative to their competitors. Even so, there has been wide recognition of a 
need for more transparency involving public scrutiny, involvement and reporting of 
regulatory policy for food.  This theme has been seen in a variety of arms-length reports to 
governments, including the recent report of the Royal Society of Canada panel on 
agricultural biotechnology, which has also argued for more provision of public funding of 
research to assess and measure possible impacts of agricultural biotechnology (Royal 
Society, 2001).  
Other focal points of public discussion about regulatory policy have included how 
information policies for consumers relating to agricultural biotechnology may best be 
provided, whether through food-labelling regulations, or by other means (like point of sale 
information, toll-free phone lines, or web-information) of providing information on food 
content, ingredients and process. This ongoing debate includes whether there should be 
mandatory labelling of GM foods and ingredients, as versus providing for voluntary 
labelling.  Related issues of labelling include the appropriate tolerance levels of genetically 
modified ingredients, in processed or prepared foods, that would be associated with labelling 
or other information statements about the content—or absence--of GM ingredients
9. 
Associated with this is the need to avoid misleading or fraudulent labelling statements. 
Consequently it is necessary to develop procedures by which informational statements on 
labels may be verified. Typically these involve methods of “identity preservation” based on 
product segregation, with associated procedures for monitoring and certification.  
The variety of different national reports of government-commissioned or arms-length 
consultations on GM foods, and the differences in the resulting political decisions to follow 
particular regulatory policies, provide one means of assessing the nature of consumers’ 
perceptions of food biotechnology. The differences in these policies in different nations 
suggest that there are appreciable national differences in consumers’ perceptions and 
attitudes to agricultural biotechnology. There have been fairly recent regulatory decisions in 
numbers of countries that will provide for mandatory labeling of genetically modified foods, 
in regions as diverse as the European Union, Switzerland, Japan, South Korea, Australia and 
New Zealand (OECD, 2000a,d).  Although mandatory labeling of food derived from 
agricultural biotechnology has been advocated by some groups in North America, this is not 
expected to occur in the United States (USDA, 2000).  
A policy of providing for voluntary rather than mandatory GM labelling has been 
proposed by Canada’s federal government. However, a private member’s bill that would 
amend the Food and Drugs Act to provide mandatory labelling for GM foods (Bill C-278) 
was tabled for first reading in the Parliament of Canada in early 2001. In April 2001, the 
Government of British Columbia also proposed, for first reading, an “exposure  bill” (Bill18-
                                                 
9 In practice a de minimus or tolerance level, ie a criterion to specify the absence of a particular component or  
ingredient, needs to be defined since an absolute definition of “zero-content”  is infeasible to achieve or 
guarantee. The tolerance level of 2% GM content of foods for a claim of absence of GM content was originally 
discussed for use in the EU,  but this threshold limit has subsequently  been specified as 1%.   11 
 
2001), directed at eliciting public discussion, which outlines provincial-level legislation for 
mandatory labelling of GM foods sold within that province (BC Gov., 2001). Legislative 
proposals for mandatory labelling have also been made, but not approved, in the United 
States.  
 




The long-standing view of consumers’ interests in food safety and the associated 
process of regulation of agricultural biotechnology in North America has placed most focus 
on characteristics of food products, rather than the processes by which products have been 
developed. The approach to food regulation in Europe has tended to place more focus on 
process than in North America. This difference is also seen in labelling regulations. 
Increasingly labelling in the EU includes statements on how food products are produced or 
made (for example, free-range fowl and eggs) and identification of  regions where they are 
grown or produced. Many of these are voluntary labelling statements. Mandatory labelling of 
foods derived from modern agricultural biotechnology was adopted in the EU in 1998.  
 In North America, regulatory focus has tended to be placed on the product and 
whether this is appreciably changed by biotechnology, rather than on whether or not the 
process of biotechnology has been used in production or processing of food ingredients. 
Consequently, in North America, labelling of GM foods is only necessary if there are health 
or safety concerns (as from allergens) or significant compositional or nutritional changes in 
food from GM processes. The difference in the approaches to GM foods in Europe and North 
America has been suggested to represent a more “demand oriented approach” that focuses on 
consumer and social concerns and preferences in Europe and a more “supply oriented 
approach” in North America that focuses on supply efficiency (Haniotis, 2001). This 
characterisation is too simple to provide a full explanation of the differences in approach.  
Differences in regulatory procedures and in activist environmental groups in Europe, 
versus the United States  have been commented on as  expressions of deep-lying cultural 
differences between these regions (Zechendorf, 1998).  Differences in approaches to 
regulation and differences in the institutions and organisations that are associated with 
regulation tend to become entrenched over time; in effect, they reflect local history, culture 
and traditions. These characteristics, and the distinct differences in trust in government and 
its regulatory system in North America, as versus Western Europe, also seem to be important 
influences on the different approaches to food safety and to food biotechnology in these 
different regions.  
Some dozen GM crop varieties, including four corn varieties and one soybean variety, 
had been approved for use in the European Union (EU)  by 1998 (Goodloe, 1999). However 
the higher level of sensitivity to food biotechnology by consumers and   environmental 
groups in Western Europe, and the numbers of protests and demonstrations, especially in the 
United Kingdom and France, led to a de facto moratorium of  EU  approval processes for 
GM foods from 1999. By 2000, some 14 applications for GM licensing were reported to be 
pending (Agra, 2000). A particularly high level of concern and a high level of activism by 
environmental groups directed at food biotechnology has been seen in the United Kingdom. 
GM crop production  has not been approved.  Small GM crop trials to assess pollen drift and   12 
 
weediness led to highly publicised demonstrations by Greenpeace activists and incidents 
where these GM plots were trashed by anonymous activists (Zechendorf, 1998; Myers, 
2001). Greenpeace activists were charged with theft and damage for the 1999 destruction and 
removal of GM plants  from trial plots; the jury that heard this case acquitted these 
individuals of the theft charge and failed to reach a verdict on the charge of damage 
(Greenpeace, 2000). In early 2001, the European Parliament approved proposals to tighten 
the use of GM foods that may pave the way for the moratorium on licensing to be lifted. The 
EU rules would require mandatory labelling and monitoring of GM foods, feeds, seeds and 
pharmaceuticals (OECD, 2000e; Europa, 2000a; Agra, 2000; CBC, 2001).  
Increased levels of interest and concern about food biotechnology have led to various 
types of consultations by the food regulatory bodies in both Canada and the United States. 
Mandatory process-based labelling of GM foods has been discussed but not introduced in 
either nation. In recognising the increasing level of public interest in labelling of GM foods, 
Canadian food safety regulators moved to provide for a policy of voluntary labelling related 
to GM foods.
 This is also the policy toward labelling of GM foods in the United States. 
Efforts to develop a consultative process to establish guidelines for voluntary GM labelling 
have been pursued through consultative discussions of the Canadian General Standards 
Board (CGSB) that have involved the Canadian Council of Grocery Distributors and 
numbers of other stakeholder and interest groups. Meetings of CGSB on voluntary labelling 
began in 1999 and proceeded throughout 2000. Consensus on a code of practice for GM 
labelling had not been achieved by early 2001. One issue of dispute related to the definition 
of GM (National Dairy Council, 2001).  
Dispute about the definition of GM  reflects fears  by producers and the food industry 
that potential statements of  “contains GM ingredients”
10 may raise a red flag suggestive of 
impaired food safety. This is, for example, reported from a 1999 study, based on focus group 
assessments, conducted by the National Institute of Nutrition (NIN, 1999). Assessments of 
unexplained phrases “genetically modified” or “biotechnology” usually prompted a defensive 
reaction. The term “genetically modified” was associated with chemicals or additives and as 
something to avoid (NIN, 1999). The term “genetically engineered” also seems to elicit 
negative connotations.
11  
A major issue that arises from the interpretations of possible GM labelling 
declarations relates to the different approaches involved in mandatory versus voluntary 
labelling of GM foods. Underlying this is the balancing of the consumer’s “right to know” 
versus concerns that consumers not be misinformed or misled (described by some as the 
consumer’s  “need to know”).  As noted above, this issue hinges largely on concerns that in 
view of longstanding policy on labelling, consumers will anticipate that they are being 
warned of appreciable food safety consequences by label declarations such as “contains GM 
                                                 
10 Many consumers groups are very critical about label statements “may contain….”. These are viewed  as 
inadequate and  informative or reflective of incompetence by the manufacturer (CAC, 2000; Loader and 
Hensen, 1998; NIN, 1999)  
11 The discriptor “biotechnology” may not be  as unfavourably viewed as the term “genetically modified” since 
“biotechnology” may imply the application of science, rather than implying gene manipulation, which is viewed 
as unnatural (NIN, 1999). It is of interest that  the market intelligence firm Nielson tracked 5 products 
containing soy  labelled as “produced using modern biotechnology” for 10 weeks in 1997 in the Netherlands 
and found no difference in market shares for these labelled products (Marshall, 1998). The term “genetically 
engineered” may be viewed in a more negative manner.  
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ingredients”. Thus, producers and processors of foods with GM ingredients, and most 
government agencies associated with food regulation in North America, do not favour 
mandatory labelling, despite the feature that opinion polls that ask the question: “should GM 
foods be labelled?” typically obtain positive responses. In contrast, producers and processors 
of foods with ingredients that are not classified as GM appear to anticipate a possible 
competitive advantage from being able to label their foods as “contains no GM ingredients”.  
 Negative labelling claims are expected to adhere to protocols intended to reduce 
misleading inferences of reduced food safety from the claim. In early 2001, these protocols 
were still to be established in Canada, where the process of developing principles to guide 
GM food labelling had not yet reached consensus. The conventional wisdom that GM 
labelling may cause adverse reactions by consumers has, however, been queried on the basis 
that lack of familiarity is a source of public fear of harm. It  may be that more familiarity, as 
through labelling, may reduce fear (Chess, 1998). It is of interest that mandatory labelling 
has been introduced in both Canada and the United States for food that has been irradiated 
(Royal Society, 2001) which represents a precedent for  mandatory process-based food 
labelling in both these countries.  
  
Regulatory procedures for food safety in Canada  
 
  The legislative basis for regulation of food risks and the application of procedures 
directed at food safety involves the overlapping authority and actions of federal, provincial 
and municipal governments. At each level, this involves more than one agency/government 
department. Even so, Canada is one of a number of countries that have moved towards a 
centralised federal-level food inspection agency, the Canadian Food Inspection Agency 
(CFIA), as a means to streamline the process of food inspection (USGAO, 1999). CFIA 
focuses on the federal-level inspection activities associated with food safety. Health Canada 
is mandated to set the regulatory standards which CFIA is charged with enforcing. Health 
Canada also is mandated to assess CFIA activities; however, CFIA reports through the 
Ministry of Agriculture. Since 1997, CFIA has brought together food inspection services 
previously provided through four federal government departments (Agriculture and Agri-
Food Canada, Fisheries and Oceans Canada, Health Canada and Industry Canada) to 
consolidate delivery of federal food, animal and plant health inspection programs (CFIA, 
1999).  
  The division of responsibilities between Health Canada and CFIA also applies to the 
regulation of food labelling. Health Canada is responsible for labelling of health, safety, 
nutrition and composition changes. CFIA is responsible for general food labelling 
requirements, setting policy to prevent false and misleading labelling, and enforcement and 
compliance monitoring.  
  Canada’s auditor-general assessed in 1999 that CFIA reporting is such that it is 
difficult to determine how well this agency is doing its job (CFIA, 1999, annex), suggesting a 
need for more transparency in operations and more emphasis on reporting.  The assessment 
for 2000 of CFIA by the auditor-general lists several areas where more effort is viewed as 
necessary to meet performance expectations. This assessment is that CFIA needs to: relate 
levels of inspection to risks; assess related areas of food risks in the non-federally-registered 
sector of the food industry; collate and report on food borne illness and pathogen prevalence;   14 
 
and meet targets for performance reporting (Auditor-General, 2001). In general, however, 
there has been little public criticism of this agency. 
  Many aspects of regulation of food risks, including the approval processes for foods 
derived from biotechnology, are responsibilities shared by Health Canada and CFIA. Health 
Canada is responsible for assessing all new foods, including those derived from 
biotechnology, while CFIA has responsibility to perform environmental safety assessments 
on all agricultural products, including biotechnology-based products (CFIA, 1999). If the 
recommendations of the recent Royal Society panel report on agricultural biotechnology 
were to be followed, this process would provide more publicly-available information and be 
subject to independent review (Royal Society, 2001). 
  
Consumers’ Attitudes to Biotechnology : What do Recent Public Polls and Studies Tell 
Us? 
 
Attitudes toward food biotechnology in the United States and Europe are highlighted by a 
number of recent surveys of public opinion. Public opinions on a variety of social issues have 
been probed in the EU since 1973 through periodic government-sponsored polls that provide 
the basis for cross-national comparisons of attitudes within the EU. Four of the 
Eurobarometer  polls have probed attitudes to biotechnology. These were conducted in 1991, 
1993, 1996 and most recently, in late 1999  (Europa, 2000b). Public opinions of 
biotechnology in the United States and Canada have also been surveyed using a number of 
comparable questions to the Eurobarometer poll. The results for Canada, for both 1997 and 
2000, are reported by Einsiedel (1997; 2000). Comparisons of some  results of the 
Eurobarometer and the comparable US  poll have been summarised by Gaskell et al (1999). 
Public opinions and  attitudes to biotechnology in the United States and for some other 
nations have also been reported by Hoban (1998). Numerous other assessments of public 
opinion have also been undertaken. These include a recent assessment of US opinions in a 
Gallup poll conducted in October 1999 and polls by Environics which probe attitudes to GM 
in a number of countries. 
Despite the fact that many consumers report a lack of knowledge of biotechnology, 
there seems to be consistency in perceptions of the relative importance of different issues of 
food safety in numbers of different countries. Thus, Hoban reports that US respondents to 
Food Market Institute surveys ranked  microbial contamination and pesticides to be the most 
severe of a number of food safety risks. Relatively few Americans (fewer than one in five) 
saw biotechnology as a serious food safety risk. A similar pattern of  responses was reported 
for Europe (Hoban, 1998). This type of pattern in assessment of relative health risks is also 
seen in Canada. Surveys of Alberta consumers conducted in 1995 and 1999, in which people 
were asked to rank specified health risk factors, led to the highest rankings being given to 
dietary fat and cholesterol, followed by bacteria in food, then pesticides. Specified forms of 
agricultural biotechnology and food additives were ranked lower by most respondents in 
these two studies (Kuperis et al, 1996; McCann et al, 2001).    
Contrasting opinions and attitudes to agricultural biotechnology in North America, as 
versus in Europe, have been stressed by some assessments, which have typified European 
attitudes to be very critical of GM and sceptical of its benefits, in contrast  to more 
favourable or indifferent attitudes to biotechnology in the United States and Canada. There is 
appreciably less support for food biotechnology in Europe than in the United States   15 
 
However, the typification of sharply different European and American attitudes to GM needs 
some qualification (Europa, 2000a). In particular, there are sharp differences in some 
attitudes to biotechnology within Europe ( Hoban, 1998; Zechdorf, 1998; Joly and Lemarie, 
1998; Gaskell et al, 1999). While attitudes vary somewhat according to the particular 
applications of biotechnology, relatively more favourable views to some applications tend to 
be shown in Spain, Portugal and Finland, according to the latest Eurobarometer report, while 
much more negative assessments tend to be seen in Greece and Austria (Europa, 2000b; 
Gaskell, 1999). Generally there is a more favourable response to medical applications of 
biotechnology and a less favourable response to food biotechnology or crop biotechnology 
(both these terms are used, separately, in the Eurobarometer poll). The Eurobarometer 
responses suggest a less favourable reaction to the use of modern biotechnology in the 
production of food than to its use in crops. The wording of questions matters in this context 
and perhaps the concept of GM use in food, rather than crops, seems more likely to be 
imposed or involuntary, as well as being more immediate to many people.  
Hoban (1998) notes that in the three years, 1992, 1994 and 1998, some 70 percent of 
American respondents to telephone surveys were positively disposed to plant biotechnology. 
While the level of knowledge of biotechnology is not high, the evidence from repeated polls, 
such as reported by Hoban and from the Eurobarometer polls, indicate that over time, more 
people report that they have heard about or know something about biotechnology. This also 
appears to be the case in Canada and in numbers of other countries. Canadians are 
increasingly aware of biotechnology, but their images of biotechnology have been described 
as nebulous (Einsiedel, 1997). The fact that many Canadians lack precise knowledge of food 
biotechnology is confirmed by the reports of focus group assessments, such as reported by 
Sheehy et al (1998) and the National Institute of Nutrition (NIN, 1999). Increasingly, 
however, more Canadians and more Americans report some knowledge of biotechnology. 
Even so, in the US assessment in late 1999 by Gallup, only 10 % of the Gallup respondents 
stated that they had heard “a great deal about” genetically modified foods. A bare majority 
(51%) of respondents to the 1999 US Gallup poll said they supported the use of 
biotechnology in food  production (Gallup, 1999).  
Some of the discrepancy between the results of US public support for food 
biotechnology reported by Hoban and Gallup may reflect differences in questioning, as in the 
wording of  “food biotechnology” (Gallup)  rather than “agricultural biotechnology” 
(Hoban). However, it seems that public support for food biotechnology may have slipped 
somewhat in the US in 1999. This seems to be the case also in Europe, where the proportion 
of people who responded positively to questions on crop and food biotechnology was lower 
in 1999 than in 1996 (Europa, 2000b). Einsiedel (2000) also observes a perceptible shift 
towards less acceptance overall of biotechnology applications in the Canada-wide surveys 
that were conducted in 1997 and 1999.  An increase in public caution about agricultural 
biotechnology is also suggested by a more recent public opinion  poll in Canada by Pollara 
(2000).   
In contrast to the responses reported by Gallup for the United States, which reported 
that a slight  majority of Americans favour food biotechnology, the Eurobarometer 1999 
survey for biotechnology, indicated that only 31 percent of surveyed Europeans believe that 
food biotechnology should be encouraged, while 37 percent viewed food biotechnology to be 
morally acceptable. Some 43 % of surveyed Europeans considered food biotechnology to be 
useful (Europa, 2000b; OECD 2000d). The comparable 1999 poll of Canadians reported by   16 
 
Einsiedel (2000) suggests that 49 percent of Canadians favour the encouragement of food 
biotechnology; 57 percent consider food biotechnology to be useful; while 55 percent 
consider it to be morally acceptable. [In each case, following the pattern for Europeans, 
somewhat higher percentages of people  favour the encouragement of plant biotechnology for 
pest resistance and consider this to be useful than is the case for responses to these issues for 
food biotechnology; the associated percentages favouring this form of crop biotechnology are 
61%; 72%; and 55% (Einsiedel, 2000)].  
Information from the comparable US survey, reported by Gaskell et al. (1999) shows 
a similar pattern to Canada, relative to Europe. Public support is considerably higher in the 
US than in Europe for food and crop biotechnology. Overall, although the reaction of the 
public to agricultural biotechnology seems to have become somewhat more wary over time, 
this is still viewed much more positively in the United States than in most European 
countries---and it seems that this is also the case in Canada. However, it may be that 
Canadians are somewhat more wary of GM food than in the US. A 1999  Environics 
International opinion poll asked respondents in five nations “how concerned are you about 
genetically engineered foods or biotechnology?” The reply of “very concerned” was given by 
47 percent of the German respondents; 37 percent of Canadians; 28 percent of  Americans; 
and 23 percent of the Chinese respondents. However, the proportion of those who responded 
that they were either “very concerned” or “concerned” was virtually the same for both 
Canadian and American respondents, at 74 percent and 73 percent, respectively (Environics, 
1999). 
The potential benefits to individuals from biotechnology are expected to influence 
people’s approval of particular applications (Bredahl et al, 1998). Many US respondents to 
opinion surveys feel that they have benefited or will benefit from plant biotechnology and 
this is concluded to be a major element in peoples’ attitudes (Hoban, 1998). Perceived benefit 
is also considered to be the major reason for the higher levels of approval of medical 
biotechnology, especially for the development of medicines and vaccines and for genetic 
testing, relative to the lower levels of support for agricultural biotechnology that are reported 
in many nations. (Eurbarometer, 2000, Gaskell et al, 1999; Einsiedel, 2000). Focus group 
discussions in Canada reported by Sheehy et al (1998) also indicate that new technologies, 
like biotechnology, must provide clear product improvements or consumer benefits to be 
considered acceptable by many consumers. Even so, Einsiedel (2000) and Gaskell et al 
(1999) conclude that peoples’ assessments of the moral acceptability of particular 
biotechnology applications contributes to these attitudes.  
There are indications in numbers of countries that animal biotechnology is less 
acceptable than crop biotechnology (Hoban, 1998; McCann, 2001). This may reflect that 
benefits of animal biotechnology are less clear to consumers, that issues of animal welfare 
are important, and that this type of biotechnology application seems more unnatural or less 
ethical than is the case for plant biotechnology. Animal cloning and xenotransplantation 
(cross-species transplantation) are the least acceptable of various biotechnology applications 
considered in the recent Eurobarometer and companion US and Canadian polls (Gaskell et al, 
1999; Einsiedel, 2000). 
One aspect of the public debate about biotechnology relates to the feature that those 
who oppose it seem to express stronger reactions than those who support it. This is, for 
example, discerned for Canadians’ responses to genetically modified foods by Einsiedel 
(2000), who found that those who see GM food to have negative impacts appear to be more   17 
 
emphatic about their views than those who see more benefits and fewer risks from these 
foods. Scrutiny of the report of results from the 1999 Eurobarometer poll on biotechnology 
(Europa, 2000b) indicates a similar tendency for Europeans. To assess acceptability of 
animal cloning and GM food, the Eurobarometer poll specifies 13 statements to which people 
were asked to respond to a five-point  rating, ranging from totally agreement with the 
statements, to totally disagreement. Examples of the statements are: “GM food will benefit 
many people;” “ the risks of GM food are acceptable;” “if something went wrong with GM 
food it would be a global disaster;” and “the idea of GM food causes me great alarm.” As 
was observed by Einsiedel for Canada, the responses that reflect concern tend to express a 
stronger degree of alarm than the extent to which approval is indicated for those who are less 
concerned about GM food.  
A similar difference in intensity that reflects stronger negative views, relative to those 
who express positive responses to biotechnology, was also discerned in the US Gallup poll 
(Gallup, 1999).  As in all surveys of public policy issues, there is a  question of whether such 
patterns of responses do in fact reflect differences in the intensity of respondents’ attitudes or 
whether this  reflects a strategic bias whereby those people opposed to a change in existing 
circumstances emphasise or overstate their reactions in an attempt to influence policy 
outcomes 
 Another feature of interest from the Gallup poll is that those who reported having 
heard a great deal of information about biotechnology tended to be most supportive of this 
technology. This has also been observed in a number of other polls and studies, as has the 
feature that more opposition tends to come from those with lower incomes and lower levels 
of education.  The tendency for women to express a higher level of concern with issues that 
may be associated with food safety is also seen in numbers of these polls and associated 
studies (Hoban, 1998;Europa, 2000b; Einsiedel, 2000; Gallup, 1999; Kuperis et al, 1996, 
1999, McCann et al, 2001).  
Several of the polls noted above have queried perceptions of risk for GM foods. Some 
58 percent of responding Canadians agreed, in early 2000, that there are risks in using food 
biotechnology; 49 percent of respondents agreed that plant biotechnology involves 
risk
12(Einsiedel, 2000). It is of interest that these are about the same percentages  reported for 
EU respondents, on average, from the 1999 Eurobarometer poll. This poll indicated that food 
biotechnology was viewed to be risky by 59 percent of EU respondents while crop 
biotechnology was viewed as risky by 49 percent; these percentages for the EU had not 
changed appreciably from 1996 (Europa, 2000b). Despite the views of many scientists and 
regulators that to this point, foods derived from approved agricultural biotechnology are 
equivalent to their traditional forms, the possibility of some risk is perceived by numbers of 
people.  
Studies of risk perception show that the type of risk that consumers face has a large 
impact on their risk tolerance. People typically have much higher levels of aversion to 
involuntary risks than to voluntary risks. With involuntary risk situations, it is not possible 
for individuals to control the level of risk to which they and their family members are 
exposed. It can, therefore, be expected that consumers will not favour the introduction of new 
                                                 
12 In the 1999 US Gallup poll, 27% of the Gallup respondents agreed that they believed food biotechnology  
poses a serious health hazard to consumers (Gallup, 1999). It is not clear that this figure can be directly 
compared to the risk perceptions cited here for the EU and Canada which are based on “mostly or totally agree” 
responses (Europa, 2000b).    18 
 
food technologies that may have a potential possibility of increasing involuntary risk, unless 
the new food technologies are seen to offer them direct benefits of some form. This does not 
yet seem to be the case for agricultural biotechnology.  
The literature on risk perception also indicates that perceptions of outrage and dread 
can arise when risks are imposed, poorly understood and may have (or be perceived to have) 
dire consequences (Fischoff et al, 1978; Slovic, 1987; and Hadden, 1989). Recognition of the 
influence of these factors on individual’s risk perceptions helps to explain consumers’ 
wariness about biotechnology and food (Wohl, 1998). Overall, the increasing awareness of 
issues of food safety, the increasing numbers of media stories on biotechnology, the fact that 
for most people, biotechnology is a poorly understood process that is seen to be “unnatural”, 
combined with the feature that food is a basic necessity of human life, seem to  be significant 
factors that contribute to an apparent trend of increasing unease of numbers of consumers 
with genetically modified foods.  
An important facet of the differences between attitudes in North America and Europe 
to biotechnology seems to be the level of trust in government and in its regulatory systems. 
There appears to be a high level of scepticism of  the capabilities and effectiveness of the 
scientists, bureaucrats and elected politicians that operate or oversee the regulatory system  
for food safety in Europe. Faith in scientists and the food safety regulatory system in many 
European nations has been greatly eroded due to a series of food safety problems, 
particularly the British “mad cow” crisis, involving transmissible  Bovine Spongiform 
Encephalopathy (BSE), which subsequently also emerged as  a food safety problem in 
continental Europe. Other food safety scares and crises have included dioxin-contaminated 
livestock feed in Belgium. It seems likely that the level of public belief in the ability of 
officials to assure safety of foods was severely harmed by the persistent initial dismissal of  
human health implications of BSE in the United Kingdom.  
The European public expresses much less trust in national governments and industry 
than in the United States. Most trust seems to be expressed in consumer and environmental 
groups in Europe (Hoban, 1998). From the 1999 Eurobarometer poll, the most trusted of 
listed sources of information on modern biotechnology were, in order, consumers’ 
associations, just ahead of the medical profession, followed by environmental protection 
associations. (The Eurobarometer also shows that Europeans’ trust in environmental 
associations as a source of information on agricultural and food biotechnology has fallen 
appreciably from earlier levels). Public authorities are not rated highly; national public 
authorities are assessed to be trustworthy by only 15 percent of respondents to the 1999 
Eurobarometer poll;  the same proportion of respondents that expressed trust in farmers’ 
associations.  The figures for consumer associations and environmental protection 
organisations are 53 percent and  45 percent respectively. (Europa, 2000c).  
In contrast to Western Europe, at this point in time, there does not seem be 
widespread distrust in the system of food safety regulation in the United States. Hoban found 
acceptance of food biotechnology to increase appreciably when consumers could be told that 
groups like the American Medical Association and the Food and Drug Administration (FDA) 
had determined particular foods from agricultural biotechnology to be safe (Hoban, 1998). In 
the 1999 US poll that followed the pattern of the Eurobarometer, those interviewed were also 
asked “if the US Department of Agriculture (USDA) made a public statement about the 
safety of biotechnology, would you have a lot, some, or no trust in the statement about 
biotechnology?” Ninety percent of respondents indicated that they would trust USDA   19 
 
statements. A similar question was asked about the FDA and this agency was supported as a 
source of trustworthy information by 84 percent of US respondents (Gaskell et al, 1999).   
Overall, there appears to be a relatively high level of trust in the regulatory procedures for 
food safety in the US. Even so, FDA noted in May 2000 that in response to input from public 
outreach meetings, it will increase its level of scrutiny of bio-engineered food and animal 
feeds (EPA, 2000). 
Although there are suggestions that some Canadians may be slightly less comfortable 
with agricultural biotechnology than is the case for many Americans, the level of trust in the 
regulatory system for food safety in Canada seems to be as high, or even slightly higher than 
in the United States. This is suggested by the 1999 Environics International poll, which 
queried people in different countries on their views of the safety of food from different 
sources. A high proportion of Canadians answered that they were “very confident” of the 
safety of food from Canada (59%); the proportion of  Americans that  responded  that they 
were “very confident” of  the safety of US food was somewhat lower (46%). Overall, 
however, the total proportion of both Canadians and  Americans that indicated they were 
either “very confident” or “confident” in the safety of food from their own country was 
remarkably similar---98 percent of Canadians and 96 percent of Americans gave these 
responses (Environics, 1999).
13   
Most food safety incidents in Canada that have originated in the food processing 
sector have involved microbial contamination, typically of meat. Product recalls, allied with 
trace back procedures, have been applied and there appear to have been few incidents of 
regulatory failure.  Nonetheless, there have been criticisms of slowness in Canadian 
regulatory procedures and confusion in communications in the public debate over whether or 
not Canada would follow the lead of the US in licensing rBST as a means to stimulate milk 
output of dairy cows (Powell and Leiss, 1997). In 1999 Canada determined not to license 
rBST for use in Canada, largely on animal welfare grounds (Kuperis et al, 1999). 
One instance of failure in the regulatory and marketing system for GM food  occurred 
in the United States, in Fall 2000, with Aventis’ StarLink corn, a GM crop variety that had 
been genetically modified to introduce insect (European corn borer) resistance. StarLink had 
received regulatory approval for commercial use by the US Environmental Protection 
Agency as a livestock feed and in industrial uses (ie for ethanol production),  but this corn 
variety had not been approved for food, since it contained a modified protein (Cry-9C) that 
could possibly cause allergic reactions for humans. Traces of this modified protein were, 
however, found in taco shells and other foods. Product recalls were instituted by US 
regulators and Aventis engaged in a “buyback” program for corn from affected farmers, 
including those with bordering crops of corn. Subsequently traces of the modified protein 
were also found in a corn cargo exported to Japan, although reportedly this had been tested in 
the United States. This touched off a reduction in purchases of US corn by importers in both 
Japan and Korea. Aventis subsequently requested cancellation of the registration for 
StarLink; three senior US managers lost their jobs with the company. Aventis, which is a 
                                                 
13 Even so, the responses of Canadians to a section of the Eurobarometer poll that asked whether named groups 
were “doing a good job for society” ranked “government in making regulations on biotechnology” below eight 
other named groups (Einsiedel, 2000). These groups were, in order of assessment of “doing a good job”: 
farmers (thought by 72 % to be doing a  good job); scientists (70%), consumer organisations (62%), shops 
(54%), media reporting (50%); industry (50%); and government (32 %). 
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major European (French)-based “life sciences” firm, separated its crop science division from 
the parent company, reportedly in order to focus on pharmaceutical products (EPA, 2000b; 
Reuters, 2001a,b; Forbes, 2001; Business Journal, 2000). 
The extent of the impact of the StarLink incident on US consumers’ trust in the 
marketing system and regulatory processes for GM foods remains to been seen. In general, 
adverse effects on  levels of trust can be expected  in situations where trust is found to have 
been misplaced or violated. Also to be seen is whether there is a spill-over effect in a loss of 
trust from StarLink onto the marketing and regulatory systems for GM food in Canada. 
StarLink was not licensed for use in Canada; spokesmen for Canada’s regulators claim that 
Canada’s policy on licensing of GM crops is more rigorous than in the US; food products 
with the suspect ingredient were not manufactured in Canada and imports, if any, were minor 
(Manitoba Co-operator, 2000b; CBC, 2000). These factors may reduce potential adverse 
spill-over effects of the StarLink situation on Canadian attitudes to trust in the food 
regulatory system in this country. Most Canadians seem to trust the safety of their food 
system, but numbers of people indicate that food safety issues are more of a concern to them 
than in earlier years (Angus Reid, 2001). While public knowledge of the technology involved 
in new foods is not widespread, public wariness of agricultural biotechnology seems to be 
increasing (Pollara, 2000). 
 
Further Discussion, Summary and Conclusions 
  
Differences in the regulation of agricultural biotechnology in different regions of the world 
suggest that attitudes of different groups of people to biotechnology can vary greatly. 
However, perceptions of risks associated with agricultural biotechnology seem to be 
increasing as more people hear something about or learn something about biotechnology. 
Thus the level of concern about agricultural biotechnology seems to be  increasing as public 
awareness of this new technology increases. Much of the increased awareness may have 
come from the increased numbers of newspaper headlines and from television stories on 
biotechnology.  Even so, consumers’ views on biotechnology evidently show considerable 
variation. Some of these differences have been ascribed to differences in the cultural and 
regulatory environments of people in different regions and countries. It seems that 
differences in the regional location of consumers, their ethnicity and their level of confidence 
in the regulatory system (and thus whether there is a history of any errors or problems in their 
national food safety systems), are important features that affect attitudes to food 
biotechnology.  
Increased public interest is seen on issues of food labelling and polls have suggested 
that many members of the public agree with statements that biotechnology- derived food 
should be labelled. In Europe, in particular, labelling is being viewed as a means to provide 
for the fundamental right of consumers  to knowledge about the products that they may 
purchase and mandatory labelling is being pursued. In North America, industry and 
regulators do not view labelling as the best means to provide information that relates to 
process, rather than content, of food and voluntary labelling seems more likely to be adopted 
for GM foods. This decision is motivated, at least in part by the concern that unnecessary 
scare messages may be interpreted from label statements of genetically modified foods. 
Mandatory labeling that signifies the possibility of allergens or appreciable differences in 
product composition or nutrition is, however, a standard requirement of food safety   21 
 
regulations in Canada, as well as in the United States and in Western Europe, and this 
requirement  is seen to be of particular importance to consumer groups.  
Detailed studies of consumers’ attitudes to possible food risks suggest that differences 
in attitudes are associated with gender, education and with the level of income of the 
consumer ( Hoban, 1998; Kuperis et al. 1996, 1999; Gallup, 1999; Eurobarometer, 2000b). 
Typically women appear to express more concern about issues of food safety. People with 
higher levels of income also tend to express more concern about food safety but there is also 
evidence that this group of people tends to be less concerned about food biotechnology. 
People with lower levels of education tend to express more concern about food 
biotechnology. 
The level of trust in the regulatory system to ensure food safety evidently varies in 
different nations and this feature seems to be one of the important determinants of cross-
national differences in perceptions of biotechnology. While most Canadians appear to  trust 
the safety of the food system, there are indications that trust in the regulatory system of 
government may be somewhat less than in earlier years. Differences in consumers’ views of 
biotechnology can be seen both within and across national borders, but one common feature 
of these views since the later 1990’s is an increasing awareness of biotechnology and an 
increasing wariness of this. It seems that the differences between nations in consumers’ 
attitudes to food biotechnology may be growing somewhat narrower, rather than widening. It 
may follow that the cross-national differences that have existed in regulatory approaches and 
procedures related to food biotechnology may also move somewhat closer over time.  
 A second common feature of consumers’ attitudes to biotechnology seems to involve 
the differentiation in attitudes towards the focus of biotechnology. People are more 
concerned about some forms of biotechnology. Thus, while there is increased consumer 
awareness of both agricultural and medical biotechnology, there seems to be a considerably 
higher level of acceptance of pursuit of biotechnological procedures in the medical area, 
while rather more concern tends to be expressed by some consumers about agricultural 
technology. More concern seems to be expressed about agricultural biotechnology involving 
animals than plants. 
Amongst the broad issues of public policy relating to food, questions of public policy 
relating to genetically modified foods are particularly complex. Consumers’ attitudes seem to 
be changing and regulations are changing in response to this. There seems to be an increasing 
level of interest of many members of the public in food policy. This is tending to extend 
beyond narrow questions of food safety to encompass ethical, social and environmental 
aspects of food production and processing. There are pressures for increased public 
participation in and transparency of regulatory processes for food risks and food 
biotechnology.  
A further element of complexity is that government policies and regulations must 
necessarily be considered in a global context that recognises the multilateral relationships 
between food policy and trade policy. Fears that food policy may be used as a disguised 
means to maintain or increase agricultural protectionism by some nations are of concern to 
farmers and governments in many agricultural exporting nations.  
Consumers’ perceptions of biotechnology are evidently complex and these attitudes 
and perceptions are changing. Biotechnology raises complex questions and issues of ethics, 
environment, economics and law.  One challenge is to develop appropriate public policy that 
will encourage the potential benefits of the powerful new tools of molecular biology that give   22 
 
effect to biotechnology in ways that will optimise benefits to society.  Issues related to this 
are likely to be a major facet of public policy for food, agriculture, and industry as well as for 
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